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formulation of an intervention to cooperate between cardiology
and gastroenterology departments of the hospital and to explore
the truths behind Hepatitis-B effecting multiorgan systems.
Methods: Cross-sectional analytical study was conducted at PIMS
Hospital, Islamabad from March 2007 to August 2008. Conﬁrmed
cirrhotic end-stage liver disease HEP-B patients were recruited.
An equal numbers of non-cirrhotics were also taken as control.
ECG was recorded and values of HR and QTc were calculated.
Comparison of increased frequency of HR and prolongation of QTc
were done using Chi-square (biostatistical) Test with signiﬁcance
level at 0.05 and using SPSS15 software. Curves of HR and QTc
were plotted for the presence of cirrhosis.
Results: 78 conﬁrmed patients of HEP-B cirrhosis of liver along
with the same number of non-cirrhotic patients as control. The
mean ± SD of QTc of cirrhotic Group was 0.438±0.015 sec and
that in non-cirrhotic group was 0.432±0.010 sec and that for HR
in cirrhotic and non cirrhotic were 78.34±12.15 and 74.98±8.03
beats/min respectively. The mean QTc and HR values were signif-
icantly more among cirrhotic as compared to non cirrhotic with
p=0.006 and p=0.043 respectively.
Conclusion: Means of both HR and QTc were signiﬁcantly higher
in cirrhotic patients as compared with non-cirrhotic controls.
The data can be used in future in making and correlating cardiac
diseases with liver problems specially hepatitis B infections.
PP-044 Study on characteristics of Th17 in
HBV-associated acute on chronic liver failure
patients and the correlation with prognosis
Fang Lin*, Jiyuan Zhang, Huifen Wang, Fusheng Wang. Beijing
302 Hospital, Beijing, PR China
Background: People’s health were threatened by hepatitis B
virus-associated acute on chronic liver failure (HBV-ACLF). No
one reported the characteristics of Th17 in HBV-ACLF patients
and the immunological markers related to prognosis of HBV-ACLF
are lack.
Methods: Th17 frequency and IL-17 levels were measured on
admission in 48 HBV-ACLF, 40 chronic hepatitis B (CHB)and 38
decompensated cirrhosis (HBV-LC) patients without bacteria or
fungus infection simultaneously, 23 heathy cases (HC) were con-
trolled. Th17 frequency, as well as the plasma concentration of
IL-17 and liver tissue in situ IL-17 expression were compared
among the four different groups. Dynamic deteciotns of Th17
frequency of 48 HBV-ACLF patients on 2, 4 and 12weeks.
Result: Th17 frequency and IL-17 concentration in peripheral
blood of HBV-ACLF patients were higher than HBV group, HBV-
LC group and the healthy control group. Intrahepatic in situ
expressions of IL-17 in ACLF group were higher than those in
CHB, HBV-LC and HC. The Th17 frequency in peripheral blood
of survival ACLF patients were signiﬁcantly lower than the non-
survival patients. The frequency of Th17 decreased gradually in
survival group, Th17 frequency of non-survival group increased.
The frequencies of Th17 changes of 2 weeks to admission were
correlated with the prognosis in HBV-ACLF patients.
Conclusion: Th17 and IL-17 expressions increase in HBV-ACLF
patients. Th17 can be served as an immunological marker of
prognosis in HBV-ACLF patients.
PP-045 Effect of combination millimeter wave irradiation
on hepatic cellular cancer patient
Jinglong Chen*. Beijing Ditan Hospital, Beijing, China
Objectives: Combination MWI (millimeter wave irradiation)
called IZL-2003 immunotherapy system irradiate marrow and
Chinese channel and point, The aim was to promote bone mar-
row cell regeneration or proliferation, and increased white blood
cell count, improve patient’s quality of life and tumor immunity
function.
Methods: there was 61 selected HCC patients, 40 cases of the
total was in treatment group, MWI and general liver aids was
administered together, 21 cases was as control group with only
general liver aids, combination MWI include constant amplitude
EHF (extremely high frequency), pulse EHF and poly-energy EHF,
Irradiation frequency was between 35GHz and 42.8 GHz.
Results:MWI increased white blood cell count and haematoglobin
level for HCC patients with lower white blood cell, P value was
0.028 and 0.017 respectively, T cell subgroup CD4+ count was
raised after MWI, when CD4+ count was below 400 cells/μl, CD4+
count was raised signiﬁcantly. Otherwise, MWI improve effec-
tively symptom, appetite, physical capacity and other quality of
life. So it raised Karnofsky score, effective rate was above 80%,
P<0.05.
Conclusion: MWI increased white blood cell and haematoglobin
level for HCC patients with lower white blood cell. It was adapt
to the patient with lower white blood cell and anaemia, and
improved immunity function and other quality of life. It will be
Cooperated with radiotherapy and chemotherapy without trauma
and side effect for patients.
PP-046 The clinical features of hepatogenous diabetes
Chunyan Jiang*. Comprehensive Department, Beijing Friendship
Hospital, Capital Medical University, Beijing, China
Objectives: To investigate the clinical features and the possible
etiology of hepatogenous diabetes.
Methods: One hundred and two cases with hepatogenous dia-
betes were retrospectively analyzed and compared with those of
primary type 2 diabetes mellitus.
Results:Only 17% of patients with hepatogenous diabetes showed
the typical diabetic symptoms such as dry mouth, polydipsia,
polyphagia, polyuria, et al. The patients with hepatogenous dia-
betes showed fasting plasma glucose (FPG) as (7.8±2.6) mmol/L
and postprandial plasma glucose (PPG) as (12.7±3.0)mmol/L.
In oral glucose tolerance test (OGTT), The patients with hep-
atogenous diabetes showed a much lower level of FPG than
that of primary type 2 diabetes mellitus (P<0.01). In insulin
and C-peptide release test, both the two groups showed a de-
layed insulin peak, but the patients with hepatogenous diabetes
showed higher insulin values at all the four periods of time than
those of primary type 2 diabetes mellitus (P<0.05). After the
treatment of diet control together with the use of insulin or
other oral drugs, most patients showed normal or near normal
levels of blood glucose. Only 5 cases had diabetic complications,
and 4 cases died of complications of underlying chronic hepatic
diseases.
Conclusion: The hepatogenous diabetes is clinically asymp-
tomatic, and is characterized by higher PPG. The insulin treat-
ment is effective for the patients with hepatogenous diabetes,
and the short-time poor prognosis is more likely to be affected
by the underlying hepatic disease. Insulin resistance may play a
central role in the etiology of the hepatogenous diabetes.
PP-047 Naloxone in the management of hepatic
encephalopathy
Ming-Hua Zheng*,1, Qian Jiang2, Ke-Qing Shi 1, Yong-Ping Chen1.
1Department of Infection and Liver Diseases, The First Afﬁliated
Hospital of Wenzhou Medical College; 2Department of Clinical
Pharmacy, West China School of Pharmacy, Sichuan University
Objectives: This study aimed to assess the effectiveness and
safety of naloxone in the management of hepatic encephalopa-
thy.
Methods: We employed the method recommended by the
Cochrane Collaboration to perform a meta-analysis of ran-
domized controlled trials of naloxone therapy for hepatic en-
cephalopathy including 17 randomized controlled trials.
